Globeflex Capital’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Globeflex Capital’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-136,581	Closed	-$423K	–	494
2021 Q4	$423K	Hold	136,581	–	–	0.09%	262
2021 Q3	$493K	Hold	136,581	–	–	0.11%	230
2021 Q2	$489K	Sell	136,581 -41,893	-23%	-$148K	0.09%	286
2021 Q1	$698K	Hold	178,474	–	–	0.13%	251
2020 Q4	$750K	Buy	178,474 +8,422	+5%	+$32.5K	0.16%	217
2020 Q3	$634K	Buy	170,052 +9,752	+6%	+$41.5K	0.17%	201
2020 Q2	$699K	Buy	+160,300	New	+$720K	0.18%	209
2013 Q3	–	Sell	-213	Closed	–	–	734
2013 Q2	$0	Buy	+213	New	+$1K	﹤0.01%	615

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $205M AUM 41.7% 1-Year Est. Return

Globeflex Capital's BDSI Position: Q1 2022 in Review

Globeflex Capital sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 136,581 shares — an estimated $423K sold.

Globeflex Capital first reported a position in BDSI in Q2 2013 and held it in 8 quarters. The position peaked at $750K in Q4 2020. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Globeflex Capital reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Globeflex Capital sold 136,581 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $423K.
Globeflex Capital first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 8 quarters.
Globeflex Capital's BioDelivery Sciences International, Inc. position peaked at $750K in Q4 2020.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Globeflex Capital's 13F filing for Q1 2022, filed 13 May 2022.